L-NBDNJ
L-NBDNJ, a glycomimetic, is an antivirulence agent. L-NBDNJ interferes with the expression of proteins regulating cytoskeleton assembly and organization of the host cell. L-NBDNJ has anti-inflammatory and anti-infective effects in models of cystic fibrosis (CF) lung disease infection[1].
Product Specifications
UNSPSC
12352005
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/l-nbdnj.html
Smiles
CCCCN1[C@@H](CO)[C@H](O)[C@@H](O)[C@H](O)C1
Molecular Formula
C10H21NO4
Molecular Weight
219.28
References & Citations
[1]Anna Esposito, et al. Assessing the Potential of N-Butyl-l-deoxynojirimycin (l-NBDNJ) in Models of Cystic Fibrosis as a Promising Antibacterial Agent. ACS Pharmacol. Transl. Sci. May 10, 2024.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC941764-100 1x 100 µL
MMP9 (Matrix Metalloproteinase 9) (2C3), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940688-500 1x 500 µL
Cytokeratin 8 (C-43), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details